Metastatic progression is associated with dynamic changes in the local microenvironment
Nicole M. Aiello, David Lawrence Bajor, Robert J. Norgard et al. · Nature Communications · 2016
Most cancer-associated deaths result from metastasis. However, it remains unknown whether the size, microenvironment or other features of a metastatic lesion dictate its behaviour or determine the efficacy of chemotherapy in the adjuvant (micrometastatic) setting. Here we delineate the natural history of metastasis in an autochthonous model of pancreatic ductal adenocarcinoma (PDAC), using lineage tracing to examine the evolution of disseminated cancer cells and their associated microenvironment. With increasing size, lesions shift from mesenchymal to epithelial histology, become hypovascular and accumulate a desmoplastic stroma, ultimately recapitulating the primary tumours from which they arose. Moreover, treatment with gemcitabine and nab-paclitaxel significantly reduces the overall number of metastases by inducing cell death in lesions of all sizes, challenging the paradigm that PDAC stroma imposes a critical barrier to drug delivery. These results illuminate the cellular dynamics of metastatic progression and suggest that adjuvant chemotherapy affords a survival benefit by directly targeting micrometastases.
Cited by 136 works. doi:10.1038/ncomms12819 Open-access PDF
Authors
- Nicole M. Aiello
- David Lawrence Bajor
- Robert J. Norgard
- Amine Sahmoud
- Neha Bhagwat
- Minh N. Pham
- Toby C. Cornish
- Christine A. Iacobuzio–Donahue
- Robert H. Vonderheide
- Ben Z. Stanger
References
- Cancer statistics, 2014
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
- Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- Molecular requirements for epithelial–mesenchymal transition during tumor progression
- Pancreatic Adenocarcinoma